Sebela Pharmaceuticals Inc.

GA · United States · Reporting entity ID 100000066371

Total reported 2019–2025

$12.2M

#438 of 2,960 reporting companies — 0% of all reported industry payments

$553K in general payments across 4,606 records, plus $11.7M in research funding across 1,612 records.

How it breaks down

General payments $553,081

Research funding $11,650,275

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.